1-1 of 1
Jeremy D. Goldhaber-Fiebert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

James I. Barnes, Vasu Divi, Adrian Begaye, Russell Wong, Steven Coutre, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1946–1956.
https://doi.org/10.1182/bloodadvances.2017015461
Published: 2018
Includes: Supplemental data